Picture of Insulet logo

PODD Insulet Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Insulet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6.816.84.6206418
Depreciation
Deferred Taxes
Non-Cash Items85.212153.757.285.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-63.4-264-2.5-191-17
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities84-68.1119146430
Capital Expenditures-167-123-157-109-134
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items18140-33.8-10.2-12.2
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities14-82.7-191-119-146
Financing Cash Flow Items-32-32.2-16.8-13.5-7.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities60640.7-40.3-13.6-28.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash708-116-11714.5249